DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tirofiban
Tirofiban
Safety of Tirofiban for Patients with Acute Ischemic Stroke in Routine Clinical Practice
Summary of the Product Characteristics
The Role of Low-Molecular-Weight Heparin in the Management of Acute Coronary Syndromes Marc Cohen, MD, FACC Newark, New Jersey
GP Iib/Iiia Adult Cardiology Treatment Dosing and Monitoring Guidelines
Summary of the Product Characteristics
Product Monograph
Intravenous Tirofiban Therapy for Patients with Capsular Warning Syndrome
GUIDELINE for ANTITHROMBOTIC REVERSAL Table 1
Estonian Statistics on Medicines 2013 1/44
Aggrastat (Tirofiban Hydrochloride Injection Premixed)
Neuraxial Access Or Peripheral Nerve Procedures)
Rescue Treatment with Intra-Arterial Tirofiban Infusion and Emergent Carotid Stenting
Glycoprotein (GP) Iib/Iiia Receptor Inhibitors for Use in Acute Coronary Syndromes (ACS) & Percutaneous Coronary Intervention (PCI)
Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01
Platelet Glycoprotein Iib/Iiia Inhibitors in Acute Ischemic Stroke
ANTICOAGULATION GUIDELINES for NEURAXIAL PROCEDURES Guidelines to Minimize Risk Spinal Hematoma with Neuraxial Procedures **
Bivalirudin Vs Heparin with Or Without Tirofiban During
Tirofiban Injection
Top View
Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury
Bericht ATC-Code B01: Antithrombotische Mittel
Clinical Efficacy and Safety of Tirofiban Combined with Conventional Dual
140-239.9 Organ Failure
Free PDF Download
Xigris, INN-Drotrecogin Alfa (Activated)
A Potential Radiopharmaceutical for Detection of Deep Venous Thrombosis
On-Pump Surgery for Acute Aortic
Management of Antithrombotic Agents in Patients Undergoing Flexible Bronchoscopy
Tirofiban 50 Micrograms/Ml Solution for Infusion
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Nursing In-Service Using Concentrated Bolus Vial (250 Mcg/Ml)
Anticoagulation Reversal
Effectiveness of Tirofiban, Eptifibatide, and Abciximab in Minimizing
Benefit of Standard Versus Low-Dose Tirofiban for Percutaneous Coronary Intervention in Very Elderly Patients with High-Risk Acute Coronary Syndrome
Use of Low-Molecular-Weight Heparins in the Management of Acute Coronary Artery Syndromes and Percutaneous Coronary Intervention
Release of Soluble CD40L from Platelets Is Regulated by Glycoprotein Iib/Iiia and Actin Polymerization Mark I
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
ANTICOAGULANT, THROMBOLYTIC, and ANTI-PLATELET DRUGS
Annex I Summary of Product Characteristics
Antiplatelet and Anticoagulant Guidelines for Coronary Stent Placement
Xigris, INN-Drotrecogin Alfa
Otto 2001 Ultrasound and Platelet Aggregation.Pdf
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Direct Thrombin Inhibitor Use During Percutaneous Coronary Intervention Spyros Kokolis, MD, Luther T
New Antithrombotic Drugs in Acute Coronary Syndrome
Tirofiban in Acute Coronary Syndrome
Tirofiban 50Mcg Sol for Inf PIL (BMXP266BND) X2
Periprocedural Antithrombotic Management for Lumbar Puncture
Resolution Ap (2000) 1
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Tirofiban (Aggrastat) for Treatment of Acute Coronary Syndrome (ACS)
Dosing and Administration
New Anticoagulants and Antiplatelet Agents : a Primer for the Clinical Gastroenterologist